XBiotech Inc.
Filed with the SEC on · accession 0001171843-26-007383
XBIT filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +1.5% by the first close after the filing.
XBiotech Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.
Close before
$1.95
Nov 11, 2026
First close after
+1.54%
$1.98
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for XBIT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for XBIT?
Click hereXBIT filed a 10-Q (SEC filing). XBiotech Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
XBIT closed at $1.95 before the filing and $1.98 on Nov 12, 2026 (+1.54%).
Get alerts when XBIT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days